Genetic Study Identifies Potential Link to Premenstrual Symptoms in Nordic Women

August 23, 2026 2 Min Read

New Genetic Insights into Premenstrual Symptoms

A recent genome-wide association study (GWAS) involving over 17,000 women with premenstrual symptoms (PSs) and nearly 55,000 controls of European descent from two Nordic cohorts has uncovered a genetic locus potentially linked to premenstrual symptoms. This research, published in Biological Psychiatry: Global Open Science, sheds light on the genetic factors that may contribute to premenstrual disorders (PMDs), conditions characterized by emotional and physical symptoms occurring prior to menstruation.

Key Findings from the Study

The study analyzed genetic data from the LifeGene cohort and the Norwegian Mother, Father and Child Cohort Study (MoBa). Researchers identified a significant association at the genetic locus 12p13.3, specifically the single nucleotide polymorphism (SNP) rs758170 near the CACNA1C gene. This SNP showed a modest protective effect against premenstrual symptoms, with an odds ratio of 0.93, indicating a slightly reduced risk. While the association was statistically significant in the combined analysis (p = 1.53 × 10^-8), it was not significant within the LifeGene cohort alone.

Additionally, six other loci demonstrated borderline significance, with three SNPs (rs76665457, rs147346386, and rs4773561) showing nominal significance in both cohorts. The estimated SNP-based heritability of premenstrual symptoms was 7.2%, suggesting a notable genetic component.

Connections to Other Conditions

Importantly, the study found a strong genetic correlation between premenstrual symptoms and major depression (genetic correlation coefficient r_g = 0.62). This finding aligns with clinical observations of overlapping mood symptoms and may indicate shared biological pathways between these conditions.

Implications for Understanding Premenstrual Disorders

Premenstrual disorders are thought to arise from heightened sensitivity to normal hormonal fluctuations during the menstrual cycle. The identification of genetic variants associated with PSs offers a promising avenue to better comprehend the underlying biological mechanisms. The CACNA1C gene, implicated in this study, is known to be involved in calcium channel functioning and has been linked to various psychiatric conditions, which may provide clues about the neurobiological aspects of PMDs.

Considerations and Future Directions

While these findings represent an important step forward, the authors caution that the results require replication in larger and more diverse populations to confirm the associations. The modest effect sizes and the complexity of PMDs suggest that multiple genetic and environmental factors contribute to symptom development. Further research may also explore how these genetic factors interact with hormonal changes and psychosocial variables.

For families and individuals affected by premenstrual symptoms, these insights may eventually guide more personalized approaches to management and treatment, although clinical applications remain preliminary.

For more detailed information, the original study can be accessed here.